Avitide, Inc., Secures Series C Financing to Expand On-demand Biopharmaceutical Affinity Purification Platform

Avitide, Inc., a biotech company dedicated to the rapid discovery and development of on-demand affinity purification solutions for the biopharmaceutical industry, today announced the closing of its Series C financing. NeoMed Management led the financing, with participation from existing investors Polaris Partners, OrbiMed Advisors, SV Life Sciences and Borealis Ventures. Claudio Nessi (NeoMed) joined Avitide’s [...]